ISSN 0253-2778

CN 34-1054/N

Open AccessOpen Access JUSTC

Expression of an Azurin mutant and its interaction with a prodrug of cisplatin

Cite this:
https://doi.org/10.3969/j.issn.0253-2778.2016.10.006
  • Received Date: 22 April 2016
  • Rev Recd Date: 07 June 2016
  • Publish Date: 31 October 2016
  • Azurin is a copper protein and possesses antitumor activity. The H117G mutant of Azurin (Az-H117G) was prepared, which is capable to bind exogenous imidazole or histidine. The interaction of Az-H117G with imidazole-based derivatives was investigated using UV-vis spectroscopy. Results show that the protein mutant can bind imidazole, histidine and Pt-His complex, a Pt(IV) prodrug of cisplatin. Based on this information, the protein/drug conjugate was prepared and the anti-proliferation of tumor cells was studied. The result indicates that this protein/drug conjugate might be potentially applicable to antitumor drug design.
    Azurin is a copper protein and possesses antitumor activity. The H117G mutant of Azurin (Az-H117G) was prepared, which is capable to bind exogenous imidazole or histidine. The interaction of Az-H117G with imidazole-based derivatives was investigated using UV-vis spectroscopy. Results show that the protein mutant can bind imidazole, histidine and Pt-His complex, a Pt(IV) prodrug of cisplatin. Based on this information, the protein/drug conjugate was prepared and the anti-proliferation of tumor cells was studied. The result indicates that this protein/drug conjugate might be potentially applicable to antitumor drug design.
  • loading
  • 加载中

Catalog

    Article Metrics

    Article views (294) PDF downloads(415)
    Proportional views

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return